1. Home
  2. SAVA vs SLND Comparison

SAVA vs SLND Comparison

Compare SAVA & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$1.98

Market Cap

156.5M

Sector

Health Care

ML Signal

HOLD

Logo Southland Holdings Inc.

SLND

Southland Holdings Inc.

HOLD

Current Price

$3.34

Market Cap

178.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAVA
SLND
Founded
1998
1900
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
156.5M
178.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SAVA
SLND
Price
$1.98
$3.34
Analyst Decision
Buy
Hold
Analyst Count
2
1
Target Price
$5.00
$4.00
AVG Volume (30 Days)
1.0M
40.9K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$935,461,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.15
$2.68
52 Week High
$4.98
$5.34

Technical Indicators

Market Signals
Indicator
SAVA
SLND
Relative Strength Index (RSI) 30.54 41.25
Support Level $2.15 $3.43
Resistance Level $3.32 $3.61
Average True Range (ATR) 0.18 0.22
MACD -0.08 -0.02
Stochastic Oscillator 1.10 22.65

Price Performance

Historical Comparison
SAVA
SLND

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

About SLND Southland Holdings Inc.

Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures. The company operates in two distinct segments: Civil and Transportation. The civil segment operates throughout North America and specializes in services that include the design and construction of water pipelines, pump stations, lift stations, water and wastewater treatment plants, concrete and structural steel, outfall, and tunneling. The transportation segment operates throughout North America and specializes in services that include the design and construction of bridges, roadways, marine, dredging, ship terminals and piers, and specialty structures and facilities.

Share on Social Networks: